Prevalence of lower extremity diseases associated with normal glucose levels, impaired fasting glucose, and diabetes among U.S. adults aged 40 or older

Diabetes Research and Clinical Practice

Volumn 77, Issue 3, 2007, Pages 485-488

  Gregg, Edward W ^a   Gu, Qiuping ^b   Williams, Desmond ^a   de Rekeneire, Nathalie ^a   Cheng, Yiling J ^a   Geiss, Linda ^a   Engelgau, Michael ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

Author keywords

National Health and Nutrition Examination Survey; Peripheral arterial disease; Peripheral neuropathy (PN)

Indexed keywords

GLUCOSE;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC FOOT; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOOT ULCER; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HEALTH SURVEY; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; LEG DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERIPHERAL NEUROPATHY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PREVALENCE; RISK FACTOR; SCREENING TEST;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; FASTING; HUMANS; LOWER EXTREMITY; MIDDLE AGED; PREVALENCE;

EID: 34547668675     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.01.005     Document Type: Article

References (34)

1. Boulton A.J., Vileikyte L., Ragnarson-Tennvall G., and Apelqvist J. The global burden of diabetic foot disease. Lancet 366 (2005) 1719-1724
2. Adler A.I., Boyko E.J., Ahroni J.H., and Smith D.G. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diab. Care 22 (1999) 1029-1035
3. Sumpio B.E. Foot ulcers. N. Engl. J. Med. 343 (2000) 787-793
4. Lehtinen J.M., Niskanen L., Hyvonen K., Siitonen O., and Uusitupa M. Nerve function and its determinants in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus and in control subjects-a 5-year follow-up. Diabetologia 36 (1993) 68-72
5. Partanen J., Niskanen L., Lehtinen J., Mervaala E., Siitonen O., and Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 333 (1995) 89-94
6. Ratzmann K.P., Raschke M., Gander I., and Schimke E. Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II (noninsulin-dependent) diabetes. J. Diab. Complicat. 5 (1991) 1-5
7. Sosenko J.M., Kato M., Soto R., and Goldberg R.B. Sensory function at diagnosis and in early stages of NIDDM in patients detected through screening. Diab. Care 15 (1992) 847-852
8. Franklin G.M., Kahn L.B., Baxter J., Marshall J.A., and Hamman R.F. Sensory neuropathy in non-insulin-dependent diabetes mellitus. The San Luis Valley Diabetes Study. Am. J. Epidemiol. 131 (1990) 633-643
9. Beks P.J., Mackaay A.J., de Neeling J.N., de Vries H., Bouter L.M., and Heine R.J. Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study. Diabetologia 38 (1995) 86-96
10. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diab. Care 12 (2003) 3333-3341
11. Hankey G.J., Norman P.E., and Eikelboom J.W. Medical treatment of peripheral arterial disease. J. Am. Med. Assoc. 295 (2006) 547-553
12. Singh N., Armstrong D.G., and Lipsky B.A. Preventing foot ulcers in patients with diabetes. J. Am. Med. Assoc. 293 (2005) 217-228
13. Gregg E.W., Sorlie P., Paulose-Ram R., Gu Q., Eberhardt M.S., Wolz M., et al. Prevalence of lower-extremity disease in the US adult population ≥40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diab. Care 27 (2004) 1591-1597
14. National Center for Health Statistics, NHANES 1999-2000 Data Files, Data, docs, codebooks, SAS code, http:///www.cdc.gov/nchs/about/major/nhanes/NHANES99_00.html, April 22 2003, Ref Type: Electronic Citation.
15. National Center for Health Statistics, NHANES 1999-2000 addendum to the NHANES III analytic guidelines, available at http:///www.cdc.gov/nchs/about/major/nhanes/guidelines1.pdf, 2003, Ref Type: Electronic Citation.
16. National Center for Health Statistics, NHANES 1999-2000 data release (June 2002), Lower extremity disease examiantion (LEX), MEC examination, http:///www.cdc.gov/nchs/about/major/nhanes/frequency/lexabdoc.pdf, 2003, Ref Type: Electronic Citation.
17. Peripheral arterial disease in people with diabetes. Diab. Care 26 (2003) 3333-3341
18. Hirsch A.T., Haskal Z.J., Hertzer N.R., Bakal C.W., Creager M.A., Halperin J.L., et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA task force on practice guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease). J. Am. Coll. Cardiol. 47 (2006) e1-e192
19. Fluckiger R., Woodtli T., and Berger W. Quantitation of glycosylated hemoglobin by boronate affinity chromatography. Diabetes 33 (1984) 73-76
20. Gould B.J., Hall P.M., and Cook J.G. A sensitive method for the measurement of glycosylated plasma proteins using affinity chromatography. Ann. Clin. Biochem. 21 Pt 1 (1984) 16-21
21. B.V. Shah, B. Barnwell, G.S. Bieler, SUDAAN User's Manual (8), 2003, Research Triangle Park, NC, Research Triangle Institute, 1999, Ref Type: Computer Program.
22. Graubard B.I., and Korn E.L. Predictive margins with survey data. Biometrics 55 (1999) 652-659
23. Mayfield J.A., Reiber G.E., Sanders L.J., Janisse D., and Pogach L.M. Preventive foot care in people with diabetes. Diab. Care 21 (1998) 2161-2177
24. Martin C.L., Albers J., Herman W.H., Cleary P., Waberski B., Greene D.A., et al. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diab. Care 29 (2006) 340-344
25. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977-986
26. Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
27. Testa M.A., and Simonson D.C. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. J. Am. Med. Assoc. 280 (1998) 1490-1496
28. Abbott C.A., Carrington A.L., Ashe H., Bath S., Every L.C., Griffiths J., et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diab. Med. 19 (2002) 377-384
29. Kumar S., Ashe H.A., Parnell L.N., Fernando D.J., Tsigos C., Young R.J., et al. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diab. Med. 11 (1994) 480-484
30. Boulton A.J., Vinik A.I., Arezzo J.C., Bril V., Feldman E.L., Freeman R., et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diab. Care 28 (2005) 956-962
31. McDermott M.M., Guralnik J.M., Albay M., Bandinelli S., Miniati B., and Ferrucci L. Impairments of muscles and nerves associated with peripheral arterial disease and their relationship with lower extremity functioning: the InCHIANTI Study. J. Am. Geriatr. Soc. 52 (2004) 405-410
32. Young M.J., Veves A., Smith J.V., Walker M.G., and Boulton A.J. Restoring lower limb blood flow improves conduction velocity in diabetic patients. Diabetologia 38 (1995) 1051-1054
33. Tesfaye S., Chaturvedi N., Eaton S.E., Ward J.D., Manes C., Ionescu-Tirgoviste C., et al. Vascular risk factors and diabetic neuropathy. N. Engl. J. Med. 352 (2005) 341-350
34. Adler A.I., Stevens R.J., Neil A., Stratton I.M., Boulton A.J., and Holman R.R. UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diab. Care 25 (2002) 894-899